Presenilin Complex Assembly and Intracellular Traffic

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005251
Summary
Alzheimer’s disease is a prevalent, adult-onset neurodegenerative disease that is characterized by progressive impairments in cognition and memory. Protein aggregates termed amyloids lead to the destruction of neurons, the formation of harmful brain lesions, and eventually culminate in the development of Alzheimer’s disease. Intensive research has identified the source of these harmful protein fragments as the amyloid precursor protein (APP). Studies have also identified proteins termed presenilins, as well as 3 additional accessory proteins, which function together as a unit to divide the APP. While each of these proteins has normal and essential biological functions, in the disease state they seem to function in a somewhat deregulated manner. Dr. Aridor believes greater understanding of the mechanisms that regulate the presenilin complex activity will in the future enable us to preserve its essential functions while eliminating harmful activity.
Related Grants
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Alzheimer's Disease Research
Does Alzheimer’s Disease Accelerate Brain Aging?
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
María Llorens-Martín, PhD
Current Organization
Spanish National Research Council
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University